Therapeutics Initiative |

15 Sep Best Evidence Webinar: VTE prophylaxis in medical patients: is it worth it?

Posted at 14:00h in Education, Podcasts & Videos 0 Comments

Dr. Aaron M Tejani is a researcher/educator/pharmacist with the Therapeutics Initiative (co-chair of the Education Working Group), a clinical assistant professor with the Faculty of Pharmaceutical Sciences (University of British Columbia), and Medication use evaluation...

15 Jul [120] Routine VTE prophylaxis: Is there a net health benefit?

Posted at 18:42h in Therapeutics Letter 0 Comments

Prophylaxis of venous thromboembolism (VTE) with low molecular weight heparin (LMWH) is now common for hospitalized non-surgical patients in British Columbia and much of North America. This includes patients who are at very low risk...

low molecular weight heparin Tag

15 Sep Best Evidence Webinar: VTE prophylaxis in medical patients: is it worth it?

15 Jul [120] Routine VTE prophylaxis: Is there a net health benefit?

Contact

Subscribe for Updates